SKLB 1028

• Description :

  SKLB 1028 (Ruserontinib) is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. SKLB 1028 shows excellent activity in FLT3-driven AML models and considerable potency in CML models containing Abl mutants.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  443.55

• Molecular Formula :

  C24H29N9

• Notes :

  Research use only, not for human use.

• Receptor :

  EGFR | FLT | Bcr-Abl

• CAS Number :

  1350544-93-2